Targeting MRS-Defined Dominant Intraprostatic Lesions with Inverse-Planned High Dose Rate Brachytherapy
Abstract
During these three years we have obtained CHR approval (December 2004)from the three step process (G.U. P.R.C. and C.H.R.) committees at UCSF. D.O.D. CHR approval was finally obtained in December 2006. Patient enrollment will begin immediately after receiving UCSF-CHR re-confirmation. We have developed a deformable image registration method to improve the quality of registration of (probe-in) MRSI data for (probe-out) radiation treatment planning. A similarity index (SI) of 98.1 % was obtained for rigid probe patient data. We have also obtained a class solution for the boost of DIL defined by MRI/MRSI as well as for the sparing of organs at risk including bladder rectum urethra and penile bulb. Patients enrollment will be initiated shortly.
Document Details
- Document Type
- Technical Report
- Publication Date
- Feb 01, 2007
- Accession Number
- ADA470893
Entities
People
- I-chow Hsu
- Jean Pouliot
- John Kurhanewicz
- Sue Noworelski
Organizations
- University of California, San Francisco